Designed and delivered by experts from industry and academia, this training event will provide a comprehensive overview of the pre-clinical drug discovery process. The workshop will focus on small molecule target identification and validation, hit-to-lead and lead optimisation, as well as on pre-clinical drug development and toxicology.
The programme will include lectures, case studies and group discussions, providing great networking opportunities and encouraging collaboration among delegates and speakers. The event is suitable for recent graduates, PhD students and early career scientists interested in working in the pre-clinical drug discovery industry.
Programme coordinators:
Rick Davies, AstraZeneca
Jacqui Piner, GSK
John Unitt, Sygnature Discovery
Heather Wallace, University of Aberdeen
John Ladbury, University of Leeds
John Colyer, University of Leeds
The event is sponsored by the Royal Society of Chemistry, and it is supported by the Royal Society of Biology and the British Pharmacological Society.
The programme will include lectures, case studies and group discussions, providing great networking opportunities and encouraging collaboration among delegates and speakers. The event is suitable for recent graduates, PhD students and early career scientists interested in working in the pre-clinical drug discovery industry.
Programme coordinators:
Rick Davies, AstraZeneca
Jacqui Piner, GSK
John Unitt, Sygnature Discovery
Heather Wallace, University of Aberdeen
John Ladbury, University of Leeds
John Colyer, University of Leeds
The event is sponsored by the Royal Society of Chemistry, and it is supported by the Royal Society of Biology and the British Pharmacological Society.
